Intensive walking exercise for lower extremity peripheral arterial disease: A systematic review and meta-analysis

Journal of Diabetes

Volumn 8, Issue 3, 2016, Pages 363-377

  Lyu, Xiafei ^a,b   Li, Sheyu ^b   Peng, Shifeng ^b   Cai, Huimin ^b   Liu, Guanjian ^b   Ran, Xingwu ^a,b  

^a Diabetic Foot Center   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Exercise; Intermittent claudication; Meta analysis; Peripheral arterial disease; Walk

Indexed keywords

6 MINUTE WALKING DISTANCE; ADVERSE OUTCOME; ARTICLE; DAILY LIFE ACTIVITY; DIABETIC PATIENT; HUMAN; INTENSIVE WALKING EXERCISE; INTERMETHOD COMPARISON; INTERMITTENT CLAUDICATION; META ANALYSIS; MUSCULOSKELETAL SYSTEM PARAMETERS; PAIN FREE WALKING DISTANCE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL PERFORMANCE; PHYSIOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SAFETY; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT DURATION; WALKING; WALKING DISTANCE; CLINICAL TRIAL (TOPIC); COMPLICATION; KINESIOTHERAPY; LOWER LIMB; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE;

CLINICAL TRIALS AS TOPIC; EXERCISE THERAPY; HUMANS; INTERMITTENT CLAUDICATION; LOWER EXTREMITY; PERIPHERAL ARTERIAL DISEASE; WALKING;

EID: 84937509236     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12304     Document Type: Article

References (62)

1. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004; 110: 738-743.
2. McDermott MM, Mehta S, Greenland P. Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease. Arch Intern Med. 1999; 159: 387-392.
3. McDermott MM, Greenland P, Liu K etal. Leg symptoms in peripheral arterial disease: Associated clinical characteristics and functional impairment. JAMA. 2001; 286: 1599-1606.
4. McDermott MM, Kerwin DR, Liu K etal. Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice. J Gen Intern Med. 2001; 16: 384-390.
5. Dolan NC, Liu K, Criqui MH etal. Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care. 2002; 25: 113-120.
6. Smolderen KG, Hoeks SE, Pedersen SS, van Domburg RT, de Liefde II, Poldermans D. Lower-leg symptoms in peripheral arterial disease are associated with anxiety, depression, and anhedonia. Vasc Med. 2009; 14: 297-304.
7. Jain A, Liu K, Ferrucci L etal. Declining walking impairment questionnaire scores are associated with subsequent increased mortality in peripheral artery disease. J Am Coll Cardiol. 2013; 6: 1820-1829.
8. 2011 Writing Group Members, 2005 Writing Committee Members, ACCF/AHA Task Force Members. 2011 ACCF/AHA Focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011; 124: 2020-2045.
9. Hirsch AT, Haskal ZJ, Hertzer NR etal. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Trans Atlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006; 113: E463-654.
10. Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2008; (4)CD000990.
11. Kruidenier LM, Viechtbauer W, Nicolaï SP etal. Treatment for intermittent claudication and the effects on walking distance and quality of life. Vascular. 2012; 20: 20-35.
12. Nicolaï SP, Kruidenier LM, Rouwet EV, Graffius K, Prins MH, Teijink JA. The walking impairment questionnaire: An effective tool to assess the effect of treatment inpatients with intermittent claudication. J Vasc Surg. 2009; 50: 89-94.
13. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. 2009; 339: B2535.
14. Higgins JP, Altman DG, Gøtzsche PC etal. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343: D5928.
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327: 557-560.
16. Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med. 1988; 7: 889-894.
17. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50: 1088-1101.
18. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315: 629-634.
19. Allen JD, Stabler T, Kenjale A etal. Plasma nitrite flux predicts exercise performance in peripheral arterial disease after 3 months of exercise training. Free Radic Biol Med. 2010; 49: 1138-1144.
20. Crowther RG, Spinks WL, Leicht AS etal. Effects of a long-term exercise program on lower limb mobility, physiological responses, walking performance, and physical activity levels in patients with peripheral arterial disease. J Vasc Surg. 2008; 47: 303-309.
21. Cucato GG, Chehuen Mda R, Costa LA etal. Exercise prescription using the heart of claudication pain onset in patients with intermittent claudication. Clinics (Sao Paulo). 2013; 68: 974-978.
22. Gardner AW, Katzel LI, Sorkin JD, Goldberg AP. Effects of long-term exercise rehabilitation on claudication distances in patients with peripheral arterial disease: A randomized controlled trial. J Cardiopulm Rehabil. 2002; 22: 192-198.
23. Gardner AW, Parker DE, Montgomery PS, Scott KJ, Blevins SM. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: A randomized controlled trial. Circulation. 2011; 123: 491-498.
24. Gardner AW, Montgomery PS, Parker DE. Optimal exercise program length for patients with claudication. J Vasc Surg. 2012; 55: 1346-1354.
25. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation. 1990; 81: 602-609.
26. Hiatt WR, Wolfel EE, Meier RH, Regensteiner JG. Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response. Circulation. 1994; 90: 1866-1874.
27. Hodges LD, Sandercock GR, Das SK, Brodie DA. Randomized controlled trial of supervised exercise to evaluate changes in cardiac function inpatients with peripheral atherosclerotic disease. Clin Physiol Funct Imaging. 2008; 28: 32-37.
28. Kruidenier LM, Nicolaï SP, Rouwet EV, Peters RJ, Prins MH, Teijink JA. Additional supervised exercise therapy after a percutaneous vascular intervention for peripheral arterial disease: A randomized clinical trial. J Vasc Interv Radiol. 2011; 22: 961-968.
29. McDermott MM, Tiukinhoy S, Greenland P etal. A pilot exercise intervention to improve lower extremity functioning in peripheral arterial disease unaccompanied by intermittent claudication. J Cardiopulm Rehabil. 2004; 24: 187-196.
30. McDermott MM, Ades P, Guralnik JM etal. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: A randomized controlled trial. JAMA. 2009; 301: 165-174.
31. McDermott MM, Liu K, Guralnik JM etal. Home-based walking exercise intervention in peripheral artery disease: A randomized clinical trial. JAMA. 2013; 310: 57-65.
32. Mika P, Spodaryk K, Cencora A, Mika A. Red blood cell deformability in patients with claudication after pain-free treadmill training. Clin J Sport Med. 2006; 16: 335-340.
33. Mika P, Wilk B, Mika A, Marchewka A, Nizankowski R. The effect of pain-free treadmill training on fibrinogen, haematocrit, and lipid profile inpatients with claudication. Eur J Cardiovasc Prev Rehabil. 2011; 18: 754-760.
34. Nicolaï SP, Teijink JA, Prins MH, Exercise Therapy in Peripheral Arterial Disease Study Group. Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication. J Vasc Surg. 2010; 52: 348-355.
35. Treat-Jacobson D, Bronas UG, Leon AS. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication. Vasc Med. 2009; 14: 203-213.
36. Tsai JC, Chan P, Wang CH etal. The effects of exercise training on walking function and perception of health status in elderly patients with peripheral arterial occlusive disease. J Intern Med. 2002; 252: 448-455.
37. Wind J, Koelemay MJ. Exercise therapy and the additional effect of supervision on exercise therapy in patients with intermittent claudication. Systematic review of randomised controlled trials. Eur J Vasc Endovasc Surg. 2007; 34: 1-9.
38. Gommans LN, Saarloos R, Scheltinga MR etal. Editor's choice: The effect of supervision on walking distance in patients with intermittent claudication: A meta-analysis. Eur J Vasc Endovasc Surg. 2014; 48: 169-184.
39. Nordanstig J, Broeren M, Hensäter M, Perlander A, Osterberg K, Jivegard L. Six-minute walk test closely correlates to "real-life" outdoor walking capacity and quality of life in patients with intermittent claudication. J Vasc Surg. 2014; 60: 404-409.
40. McDermott MM, Guralnik JM, Criqui MH, Liu K, Kibbe MR, Ferrucci L. Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease. Circulation. 2014; 130: 61-68.
41. Hiatt WR, Rogers RK, Brass EP. The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease. Circulation. 2014; 130: 69-78.
42. Van Pul KM, Kruidenier LM, Nicolaï SP etal. Effect of supervised exercise therapy for intermittent claudication in patients with diabetes mellitus. Ann Vasc Surg. 2012; 26: 957-963.
43. Mahé G, Ouedraogo N, Leftheriotis G, Vielle B, Picquet J, Abraham P. Exercise treadmill testing in patients with claudication, with and without diabetes. Diabet Med. 2011; 28: 356-362.
44. Green S, Askew CD, Walker PJ. Effect of type 2 diabetes mellitus on exercise intolerance and the physiological responses to exercise in peripheral arterial disease. Diabetologia. 2007; 50: 859-866.
45. Gardner AW, Parker DE, Montgomery PS, Blevins SM. Diabetic women are poor responders to exercise rehabilitation in the treatment of claudication. J Vasc Surg. 2014; 59: 1036-1043.
46. Allen JD, Stabler T, Kenjale AA etal. Diabetes status differentiates endothelial function and plasma nitrite response to exercise stress in peripheral arterial disease following supervised training. J Diabetes Complications. 2014; 28: 219-225.
47. Pilz M, Kandioler-Honetz E, Wenkstetten-Holub A, Doerrscheidt W, Mueller R, Kurz RW. Evaluation of 6- and 12-month supervised exercise training on strength and endurance parameters in patients with peripheral arterial disease. Wien Klin Wochenschr. 2014; 126: 383-389.
48. Parmenter BJ, Dieberg G, Smart NA. Exercise training for management of peripheral arterial disease: A systematic review and meta-analysis. Sports Med. 2015; 45: 231-244.
49. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA. 1995; 274: 975-980.
50. Tisi PV, Shearman CP. The evidence for the exercise induced inflammation in intermittent claudication: Should we encourage patients to stop walking? Eur J Vasc Endovasc Surg. 1998; 15: 7-17.
51. Mika P, Spodaryk K, Cencora A, Unnithan VB, Mika A. Experimental model of pain-free treadmill training in patients with claudication. Am J Phys Med Rehabil. 2005; 84: 756-762.
52. Gardner AW, Montgomery PS, Flinn WR, Katzel LI. The effect of exercise intensity on the response to exercise rehabilitation in patients with intermittent claudication. J Vasc Surg. 2005; 42: 702-709.
53. Mika P, Konik A, Januszek R etal. Comparison of two treadmill training programs on walking ability and endothelial function in intermittent claudication. Int J Cardiol. 2013; 168: 838-842.
54. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med. 2002; 347: 1941-1951.
55. Haas TL, Lloyd PG, Yang HT, Terjung RL. Exercise training and peripheral arterial disease. Compr Physiol. 2012; 2: 2933-3017.
56. Laufs U, Werner N, Link A etal. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation. 2004; 109: 220-226.
57. Holm J, Dahllöf AG, Scherstén T. Metabolic activity of skeletal muscle in patients with peripheral arterial insufficiency. Effect of arterial reconstructive surgery. Scand J Clin Lab Invest. 1975; 35: 81-86.
58. Hiatt WR, Regensteiner JG, Wolfel EE, Carry MR, Brass EP. Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol. 1996; 81: 780-788.
59. Kojda G, Cheng YC, Burchfield J, Harrison DG. Dysfunctional regulation of endothelial nitric oxide synthase (eNOS) expression in response to exercise in mice lacking one eNOS gene. Circulation. 2001; 103: 2839-2844.
60. Lima A, Ritti-Dias R, Forjaz CL etal. A session of resistance exercise increases vasodilation in intermittent claudication patients. Appl Physiol Nutr Metab. 2015; 40: 59-64.
61. Januszek R, Mika P, Konik A, Petriczek T, Nowobilski R, Nizankowski R. Effect of treadmill training on endothelial function and walking abilities in patients with peripheral arterial disease. J Cardiol. 2014; 64: 145-151.
62. Collins EG, Bammert C, Edwards LC etal. Pole striding exercise and vitamin E for management of peripheral vascular disease. Med Sci Sports Exerc. 2003; 35: 384-393.